Editorial: The pathogenesis and treatment of Helicobacter pylori-induced diseases

Yifei Xu; Anna K Walduck; Huafeng Pan

doi:10.3389/fcimb.2023.1219503

Editorial: The pathogenesis and treatment of Helicobacter pylori-induced diseases

Front Cell Infect Microbiol. 2023 Jul 3:13:1219503. doi: 10.3389/fcimb.2023.1219503. eCollection 2023.

Authors

Yifei Xu¹, Anna K Walduck², Huafeng Pan³

Affiliations

¹ Department of Gastroenterology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China.
² Rural Health Research Institute, Charles Sturt University, Orange, NSW, Australia.
³ Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.

No abstract available

Keywords: Helicobacter pylori; natural product (NP); pathogenesis; spasmolytic polypeptide expressing metaplasia; treatment.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Gastric Mucosa / pathology
Helicobacter pylori*
Stomach / pathology

Grants and funding

This research was supported by the National Science Foundation of China (82204734), Scientific Research Project of Guangdong Bureau of Traditional Chinese Medicine (20221349), Shenzhen Science and Technology Innovation Commission (JCYJ20220531091815034, JCYJ20220531092401003, JCYJ20210324111602007), and Shenzhen Excellent Scientific and Technological Innovation Talent Training Project (RCBS20221008093126070). AW was funded by CSU.